Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determining Grade of Neonatal Encephalopathy - Agreement Between the Modified Sarnat Examination and Automated AI Assessment of Newborn Brain Function Using Wave Software

NCT07857070 is registered in ClinicalTrials.gov with CergenX Limited as lead sponsor.

NCT NCT07857070
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07857070 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determining Grade of Neonatal Encephalopathy - Agreement Between the Modified Sarnat Examination and Automated AI Assessment of Newborn Brain Function Using Wave Software
Lead sponsor
CergenX Limited
Phase
Observational
Overall status
Not yet recruiting
Start date
September 30, 2026
Completion date
September 30, 2027
Enrollment
165 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

neonatal encephalopathy, neonatal encephalopathy (neonatal hypoxic-ischemic encephalopathy), neonatal encephalopathy, unspecified